NEVAKAR

nevakar-logo

Nevakar is a specialty pharmaceutical company, focused on developing innovative products in injectable and ophthalmic space.Their goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts.Nevakar’s business model is supported by state of the art R&D infrastructure, located in NJ Center of Excellence, and a well experienced management and leadership team.

#SimilarOrganizations #People #Financial #Website #More

NEVAKAR

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2015-01-01

Address:
Bridgewater, New Jersey, United States

Country:
United States

Website Url:
http://www.nevakar.com

Total Employee:
11+

Status:
Active

Contact:
(908)367-7400

Email Addresses:
[email protected]

Total Funding:
135 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Mobile Non Scaleable Content


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

corvus-pharmaceuticals-logo

Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

curon-biopharma-logo

Curon Biopharma

Curon Biopharma is a Healthcare company.

cyclerion-therapeutics-logo

Cyclerion Therapeutics

Cyclerion Therapeutics is a clinical-stage biopharmaceutical company.

frontier-biotechnologies-logo

Frontier Biotechnologies

Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.

jenrin-discovery-logo

Jenrin Discovery

Jenrin Discovery is a biopharmaceutical Company.

leap-therapeutics-logo

Leap Therapeutics

Leap Therapeutics is a clinical-stage biopharmaceutical company.

ocugen-logo

Ocugen

Ocugen is a clinical stage biopharmaceutical company.

oncoquest-logo

OncoQuest

OncoQuest is a Edmonton-based biopharmaceutical company.

Current Employees Featured

sriram-ramanathan_image

Sriram Ramanathan
Sriram Ramanathan President & COO @ Nevakar
President & COO
2020-06-01

navneet-puri_image

Navneet Puri
Navneet Puri Chairman and CEO @ Nevakar
Chairman and CEO
2015-09-01

sriram-j-ramanathan_image

Sriram J. Ramanathan
Sriram J. Ramanathan CEO of Nevakar Injectables @ Nevakar
CEO of Nevakar Injectables
2021-06-01

not_available_image

Vish Shetty
Vish Shetty VP, Commercial Development @ Nevakar
VP, Commercial Development

navneet-puri_image

Navneet Puri
Navneet Puri Founder & CEO @ Nevakar
Founder & CEO
2015-09-01

sriram-j-ramanathan_image

Sriram J. Ramanathan
Sriram J. Ramanathan President & COO @ Nevakar
President & COO
2020-06-01

reema-puri_image

Reema Puri
Reema Puri Vice President Human Resources @ Nevakar
Vice President Human Resources
2015-10-01

kumaresh-soppimath_image

Kumaresh Soppimath
Kumaresh Soppimath CSO @ Nevakar
CSO
2015-11-01

Founder


navneet-puri_image

Navneet Puri

Investors List

novaquest-capital-management_image

Novaquest Capital Management

Novaquest Capital Management investment in Private Equity Round - Nevakar

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Debt Financing - Nevakar

armentum-partners_image

Armentum Partners

Armentum Partners investment in Debt Financing - Nevakar

Official Site Inspections

http://www.nevakar.com

  • Host name: 231.71.212.35.bc.googleusercontent.com
  • IP address: 35.212.71.231
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Nevakar"

Nevakar Inc. | Repositioning Drugs for a Better Outcome

Jun 18, 2024 · Vyluma Discusses Response to FDA’s Questions and Clarifies Regulatory Pathway for its 505 (b) (2) NDA. Bridgewater, New Jersey – June 18, 2024 – Vyluma, Inc. …See details»

NEVAKAR INC. ANNOUNCES FORMATION OF NEVAKAR …

May 25, 2021 · At inception Nevakar Injectables will operate as a wholly owned subsidiary of Nevakar Inc. Nevakar Injectables launches with 13 active programs, three of which have been …See details»

Nevakar - Crunchbase Company Profile & Funding

Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space. Their goal is to develop enhanced products that address unmet clinical and/or commercial …See details»

Nevakar Injectables, Inc

Hospital Injectables is estimated to be a $624.5 billion market where suboptimal products, medication delays and compounding are serious challenges for hospitals everywhere.See details»

Nevakar Inc. - LinkedIn

Nevakar is a specialty injectable pharmaceutical company, focused on developing innovative products in injectable and ophthalmic space. Our goal is to develop enhanced products that address unmet...See details»

News | Nevakar Inc.

Oct 11, 2023 · Bridgewater, NJ, May 2, 2022 – Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile …See details»

Nevakar Inc. Announces Formation Of Nevakar …

May 25, 2021 · At inception Nevakar Injectables will operate as a wholly owned subsidiary of Nevakar Inc. Nevakar Injectables launches with 13 active programs, three of which have been filed with FDA under...See details»

Nevakar Injectables Company Profile 2024: Valuation, …

Nevakar Injectables is headquartered in Bridgewater, NJ. What is the size of Nevakar Injectables? Nevakar Injectables has 53 total employees. What industry is Nevakar Injectables in? Nevakar Injectables’s primary industry is Drug …See details»

Nevakar - VentureRadar

Website: http://nevakar.com. Nevakar is leading the development and commercialization of pharmaceutical treatments in patients suffering from ophthalmic refractive errors such as myopia.See details»

NEVAKAR AND THÉA ENTER INTO LICENSING AGREEMENT FOR …

Jan 28, 2021 · Bridgewater, NJ, USA and Clermont-Ferrand, France, January 28, 2021 – Nevakar Inc. (“Nevakar”), a biopharmaceutical company developing multiple assets in the ophthalmic …See details»

Nevakar Announces Closing of $12 Million Convertible Note and …

BRIDGEWATER, N.J., March 09, 2022 (GLOBE NEWSWIRE) -- Nevakar Inc. (“Nevakar”), a biopharmaceutical company developing multiple assets in the ophthalmic and injectable areas, …See details»

Nevakar Inc. Company Profile | Bridgewater, NJ | Competitors ...

Find company research, competitor information, contact details & financial data for Nevakar Inc. of Bridgewater, NJ. Get the latest business insights from Dun & Bradstreet.See details»

Nevakar Announces Formation Of Ophthalmic Company, Vyluma

BRIDGEWATER, N.J., May 25, 2021 /PRNewswire/ -- Nevakar Inc. ("Nevakar"), a privately held biopharmaceutical company, today announces the establishment of Vyluma Inc., a newly …See details»

Nevakar - Products, Competitors, Financials, Employees, …

Nevakar is a specialty pharmaceutical company with a focus on developing injectable and ophthalmic treatments. The company's main offerings include the repositioning of approved …See details»

Nevakar Company Profile - Office Locations, Competitors ... - Craft

Nevakar is a specialty pharmaceutical company. It develops injectable and ophthalmic products. Nevakar has 5 employees across 2 locations and $85 m in total funding,. See insights on …See details»

Nevakar - Overview, News & Similar companies | ZoomInfo.com

Oct 28, 2022 · Founded in 2015 and headquartered in Bridgewater, New Jersey, Nevakar is a specialty pharmaceutical company. Is this data correct? View contact profiles from Nevakar. …See details»

NEVAKAR INC. ANNOUNCES FORMATION OF NEVAKAR …

May 25, 2021 · At inception Nevakar Injectables will operate as a wholly owned subsidiary of Nevakar Inc. Nevakar Injectables launches with 13 active programs, three of which have been …See details»

Nevakar Announces First Subject Dosed in its Phase 3 Clinical Trial …

Jan 28, 2021 · With its strong commercial organization, relationships with key opinion leaders, and deep knowledge of the ophthalmology landscape in Europe, Théa will provide NVK002 …See details»

Nevakar and zhaoke ophthalmology enter into licensing …

Oct 20, 2020 · Bridgewater, NJ (USA) and Hong Kong S.A.R., October 20, 2020 – Nevakar Inc. (“Nevakar”), a privately held, late-stage, biopharmaceutical company developing multiple …See details»

First Patient Completes Three Year Enrollment in Nevakar’s

BRIDGEWATER, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Nevakar Inc., a biopharmaceutical company developing multiple products in the ophthalmic and injectable areas, announced …See details»

linkstock.net © 2022. All rights reserved